Male Infertility Treatment Market

According to Word Health Organization, Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year . About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwillingly childless. Approximately 90% of male infertility cases are seen mainly due to low sperm counts, and poor sperm quality. The remaining cases of male infertility can be caused by a number of factors including anatomical problems, hormonal imbalances, and genetic defects.

Male Infertility Treatment Market contains market size and forecasts of Male Infertility Treatment in Global, including the following market information:

• Global Male Infertility Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Male Infertility Treatment market was valued at 1341.5 million in 2021 and is projected to reach US$ 2234.4 million by 2028, at a CAGR of 7.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

DNA Fragmentation Technique Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Male Infertility Treatment include Merck Serono, Aytu BioScience, Bayer, Cadila, Intas Pharma, Halotech DNA, SCSA diagnostics, Andrology Solutions and Livzon Pharmaceutical Group Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Male Infertility Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Male Infertility Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Male Infertility Treatment Market Segment Percentages, by Type, 2021 (%)

• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Sperm Penetration Assay

Global Male Infertility Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Male Infertility Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Male Infertility Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Male Infertility Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Male Infertility Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Male Infertility Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck Serono
• Aytu BioScience
• Bayer
• Cadila
• Intas Pharma
• Halotech DNA
• SCSA diagnostics
• Andrology Solutions
• Livzon Pharmaceutical Group Inc.
• Zhejiang Xianju Pharmaceutical Co.,Ltd.
• GeneScience Pharmaceuticals Co., Ltd.
• Abeona Therapeutics Inc.
• ASKA Pharmaceutical Co., Ltd.
• Bristol Myers Squibb
• Church & Dwight
• Intas Biopharmaceuticals
• Eli Lilly and Company